Annual CFF
-$12.54 M
-$32.22 M-163.70%
December 31, 2023
Summary
- As of February 7, 2025, TCON annual cash flow from financing activities is -$12.54 million, with the most recent change of -$32.22 million (-163.70%) on December 31, 2023.
- During the last 3 years, TCON annual CFF has fallen by -$49.30 million (-134.11%).
- TCON annual CFF is now -134.11% below its all-time high of $36.76 million, reached on December 31, 2020.
Performance
TCON Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$1.15 M
-$722.00 K-38.61%
June 30, 2024
Summary
- As of February 7, 2025, TCON quarterly cash flow from financing activities is $1.15 million, with the most recent change of -$722.00 thousand (-38.61%) on June 30, 2024.
- Over the past year, TCON quarterly CFF has dropped by -$176.00 thousand (-13.29%).
- TCON quarterly CFF is now -96.73% below its all-time high of $35.09 million, reached on March 31, 2015.
Performance
TCON Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
-$4.75 M
+$100.00 K+2.06%
June 30, 2024
Summary
- As of February 7, 2025, TCON TTM cash flow from financing activities is -$4.75 million, with the most recent change of +$100.00 thousand (+2.06%) on June 30, 2024.
- Over the past year, TCON TTM CFF has increased by +$7.79 million (+62.13%).
- TCON TTM CFF is now -107.18% below its all-time high of $66.13 million, reached on March 31, 2015.
Performance
TCON TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
TCON Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -163.7% | -13.3% | +62.1% |
| 3 y3 years | -134.1% | -76.8% | -129.1% |
| 5 y5 years | -135.5% | +4683.3% | -624.2% |
TCON Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -163.7% | at low | -89.0% | +112.6% | -124.1% | +62.1% |
| 5 y | 5-year | -134.1% | at low | -92.9% | +112.6% | -112.9% | +62.1% |
| alltime | all time | -134.1% | at low | -96.7% | +112.6% | -107.2% | +62.1% |
TRACON Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2024 | - | $1.15 M(-38.6%) | -$4.75 M(-2.1%) |
| Mar 2024 | - | $1.87 M(+41.2%) | -$4.85 M(-61.3%) |
| Dec 2023 | -$12.54 M(-163.7%) | $1.32 M(-114.6%) | -$12.54 M(+40.6%) |
| Sep 2023 | - | -$9.09 M(-967.5%) | -$8.92 M(-183.8%) |
| Jun 2023 | - | $1.05 M(-118.0%) | $10.64 M(-26.9%) |
| Mar 2023 | - | -$5.82 M(-217.7%) | $14.55 M(-26.1%) |
| Dec 2022 | $19.68 M(+86.4%) | $4.95 M(-52.8%) | $19.68 M(+40.3%) |
| Sep 2022 | - | $10.47 M(+111.1%) | $14.03 M(-14.0%) |
| Jun 2022 | - | $4.96 M(-822.9%) | $16.32 M(+52.0%) |
| Mar 2022 | - | -$686.00 K(-2.8%) | $10.73 M(+1.6%) |
| Dec 2021 | $10.56 M(-71.3%) | -$706.00 K(-105.5%) | $10.56 M(-57.0%) |
| Sep 2021 | - | $12.75 M(-2130.9%) | $24.57 M(-12.5%) |
| Jun 2021 | - | -$628.00 K(-27.0%) | $28.09 M(-14.6%) |
| Mar 2021 | - | -$860.00 K(-106.5%) | $32.89 M(-10.5%) |
| Dec 2020 | $36.76 M(+3957.8%) | $13.31 M(-18.2%) | $36.76 M(+46.7%) |
| Sep 2020 | - | $16.27 M(+289.7%) | $25.06 M(+209.7%) |
| Jun 2020 | - | $4.17 M(+38.5%) | $8.09 M(+105.3%) |
| Mar 2020 | - | $3.01 M(+88.1%) | $3.94 M(+334.9%) |
| Dec 2019 | $906.00 K | $1.60 M(-328.9%) | $906.00 K(-233.0%) |
| Sep 2019 | - | -$700.00 K(-3016.7%) | -$681.00 K(<-9900.0%) |
| Jun 2019 | - | $24.00 K(-220.0%) | $3000.00(-99.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$20.00 K(-233.3%) | $1.02 M(-97.1%) |
| Dec 2018 | $35.32 M(+962.0%) | $15.00 K(-193.8%) | $35.32 M(-2.5%) |
| Sep 2018 | - | -$16.00 K(-101.5%) | $36.23 M(-6.6%) |
| Jun 2018 | - | $1.04 M(-97.0%) | $38.77 M(+2.8%) |
| Mar 2018 | - | $34.28 M(+3630.3%) | $37.73 M(+1034.4%) |
| Dec 2017 | $3.33 M(-82.9%) | $919.00 K(-63.7%) | $3.33 M(-81.2%) |
| Sep 2017 | - | $2.53 M(>+9900.0%) | $17.69 M(-7.7%) |
| Jun 2017 | - | $1000.00(-100.8%) | $19.16 M(-0.6%) |
| Mar 2017 | - | -$124.00 K(-100.8%) | $19.28 M(-0.7%) |
| Dec 2016 | $19.41 M(-46.7%) | $15.29 M(+282.1%) | $19.41 M(+213.0%) |
| Sep 2016 | - | $4.00 M(+3205.8%) | $6.20 M(+176.8%) |
| Jun 2016 | - | $121.00 K(+1628.6%) | $2.24 M(+63.9%) |
| Mar 2016 | - | $7000.00(-99.7%) | $1.37 M(-96.2%) |
| Dec 2015 | $36.45 M(+17.5%) | $2.07 M(+5217.9%) | $36.45 M(+9.2%) |
| Sep 2015 | - | $39.00 K(-105.2%) | $33.37 M(-44.9%) |
| Jun 2015 | - | -$753.00 K(-102.1%) | $60.53 M(-8.5%) |
| Mar 2015 | - | $35.09 M(-3571.1%) | $66.13 M(+113.1%) |
| Dec 2014 | $31.04 M(+377.9%) | -$1.01 M(-103.7%) | $31.04 M(-3.2%) |
| Sep 2014 | - | $27.20 M(+461.7%) | $32.05 M(+561.7%) |
| Jun 2014 | - | $4.84 M | $4.84 M |
| Dec 2013 | $6.49 M(+63.4%) | - | - |
| Dec 2012 | $3.97 M | - | - |
FAQ
- What is TRACON Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for TRACON Pharmaceuticals?
- What is TRACON Pharmaceuticals annual CFF year-on-year change?
- What is TRACON Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for TRACON Pharmaceuticals?
- What is TRACON Pharmaceuticals quarterly CFF year-on-year change?
- What is TRACON Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for TRACON Pharmaceuticals?
- What is TRACON Pharmaceuticals TTM CFF year-on-year change?
What is TRACON Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of TCON is -$12.54 M
What is the all time high annual CFF for TRACON Pharmaceuticals?
TRACON Pharmaceuticals all-time high annual cash flow from financing activities is $36.76 M
What is TRACON Pharmaceuticals annual CFF year-on-year change?
Over the past year, TCON annual cash flow from financing activities has changed by -$32.22 M (-163.70%)
What is TRACON Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of TCON is $1.15 M
What is the all time high quarterly CFF for TRACON Pharmaceuticals?
TRACON Pharmaceuticals all-time high quarterly cash flow from financing activities is $35.09 M
What is TRACON Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, TCON quarterly cash flow from financing activities has changed by -$176.00 K (-13.29%)
What is TRACON Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of TCON is -$4.75 M
What is the all time high TTM CFF for TRACON Pharmaceuticals?
TRACON Pharmaceuticals all-time high TTM cash flow from financing activities is $66.13 M
What is TRACON Pharmaceuticals TTM CFF year-on-year change?
Over the past year, TCON TTM cash flow from financing activities has changed by +$7.79 M (+62.13%)